Tuesday, April 3, 2018

BRIEF-‍EMA To Review Dupixent As Potential Treatment For Inadequately Controlled Moderate-To Severe Asthma​

* ‍EMA TO REVIEW DUPIXENT® (DUPILUMAB) AS POTENTIAL TREATMENT FOR INADEQUATELY CONTROLLED MODERATE-TO-SEVERE ASTHMA​
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)